WAVE Life Sciences launches PRECISION clinical trial to suppress the mutant Huntington's disease protein
A potential HD biomarker has been uncovered in a recent clinical study
Deutetrabenazine becomes the first new drug in a decade licensed by the FDA for symptoms of Huntington's disease
Pfizer announces the 'Amaryllis' trial of a PDE-10 inhibitor drug failed to improve symptoms of HD
HDBuzz helps untangle some bold claims about the just-announced results of the PRIDE-HD trial of pridopidine in HD
A new scientific paper & lots of headlines about deutetrabenazine, a twist on treating chorea in Huntington's disease
HDBuzz summarizes the science from an unusually large and energized @HDSA convention in Baltimore
HD reaches more brain structures than we thought: new research broadens our understanding of the earliest signs of HD
A confusing story about a huntingtin lowering trial is published in the Telegraph, but cool new stuff is happening!